Tag: paper spotlight

HPV Therapeutic Vaccine Shows Safety but Uncertain Benefit in Preventing Head and Neck Cancer Recurrence

June 15, 2026

“PepCan does not seem to be effective in reducing recurrence; however, the results are inconclusive given the small patient numbers.” BUFFALO, NY - June 15, 2026 – A new research… read more

Oncotarget

Experimental Compounds Trigger Cancer Cell Death in KRAS-Driven Pancreatic Cancer

June 8, 2026

“Taken together, these data obtained using pancreatic cancer cells with KRAS mutations suggest the ability of the PCAIs to prevent metastasis and tumor growth, strongly indicating their potential to serve… read more

Oncotarget

Agentic AI Systems May Transform Nutritional Care in Oncology

May 11, 2026

“Cancer-related malnutrition affects up to 80% of patients and contributes to 10 to 20% of cancer deaths.” BUFFALO, NY - May 11, 2026 – A new editorial was published in… read more

Histology image of flame shaped plasma cells promoting multiple myeloma condition understanding

Oncotarget

Targeted Therapies Drive Long-Term Decline in Multiple Myeloma Mortality in the U.S.

April 29, 2026

“Multiple myeloma (MM), the second most common hematologic malignancy in the United States, has undergone transformative therapeutic innovation over the past five decades.” BUFFALO, NY - April 29, 2026 –… read more

worried female doctor holding diagnosis and consulting upset senior woman with cancer in hospital

Oncotarget

Cancer Care in Conflict Zones Remains Critically Neglected

April 13, 2026

“Cancer is an escalating yet neglected health crisis among refugees, migrants, and populations affected by conflict.” BUFFALO, NY - April 13, 2026 – A new review was published in Volume… read more

Oncotarget

Oncotarget Editorial Highlights Advances in Scientific Integrity and Publishing Transparency

April 10, 2026

“Scientific integrity is a crucial component of scholarly publishing.” BUFFALO, NY - April 10, 2026 – A new editorial perspective was published in Volume 17 of Oncotarget on April 8, 2026, titled “Oncotarget: Past,… read more

Oncotarget

Bibliometric Mapping Reveals the Evolution of Glioma Classification Research

April 6, 2026

“The findings indicate that the subset of articles focusing on glioma classification that incorporate social factors is relatively scarce in the analyzed data, in contrast to the prominence of epigenetic… read more

Oncotarget

CREB5 Linked to Stem Cell-Like Programs That Promote Prostate Cancer Progression

March 24, 2026

“We determined that CREB5 is a key regulator of basal and SCL transcriptional programs and tumor-forming phenotypes in PC.” BUFFALO, NY - March 24, 2026 – A new research paper… read more

Oncotarget

Researchers Question Editorial Bias in COVID-19 Vaccine Debate

February 16, 2026

“By the end of this commentary, it will be evident how a purported 'general scientific consensus' may have been artificially engineered by selectively prioritizing studies aligned with the established narrative.”… read more

Oncotarget

New Hypothesis Links HPV E6 and SARS‑CoV‑2 Spike Proteins to Reduced p53 Activity

January 13, 2026

“Thus, the present hypothesis is that virally encoded proteins such as HPV-E6 or SARS-COV-2 Spike may cooperate in suppressing host defenses including tumor suppressor mechanisms involving p53.” BUFFALO, NY -… read more